Raffles Consulting Services
Choose a Global Innovation Alliance Launch or Grow pathway using market evidence, product maturity, partner needs and a defined overseas decision.
The Global Innovation Alliance offers Launch and Grow pathways for different stages of overseas expansion. Launch is suited to companies still testing product-market fit and building foundational market capability. Grow is for companies ready to deepen commercial, investor or innovation activity with a clearer proposition and evidence.
Choose the pathway by the next decision the company must make, not by the ambition of the programme name.
Understand the official distinction
The official GIA overview describes Launch programmes as market insights, discovery sprints and acceleration work that help startups explore new markets, test product-market fit and develop go-to-market approaches.
It describes Grow pathways as tailored support for scaling, deeper market penetration, technology maturation, cross-border research and development, pilots and testbeds.
The same network spans more than 50 countries through partners. Availability, cohort, sector and company requirements vary, so the live programme page and partner process control the real application.
State the overseas decision
Write one question for the programme to answer. A Launch question might ask whether a defined customer segment has a problem strong enough to justify a local channel. A Grow question might ask which partner and deployment model can support a paid pilot at scale.
Avoid the broad goal of entering a country. It does not identify the customer, product, regulatory boundary or commitment the company will decide after the programme.
Set a decision date and owner. The programme should feed a commercial choice rather than become a series of meetings without a conclusion.
Test Launch readiness
Launch requires a credible product and team, but it can begin before the company has repeatable overseas sales. Prepare a concise problem statement, target customer, existing evidence, hypotheses and interview plan.
Define the assumptions to test: buyer, use case, willingness to pay, procurement route, regulation, localisation, partner need and competitive alternatives. Rank them by risk.
The international IP market-route guide shows a separate issue that can arise during expansion. Do not choose IP markets before the commercial market evidence is clear.
Test Grow readiness
Grow is more suitable when the company can show product performance, customer evidence, delivery capability and a specific scaling barrier. Prepare current market results, referenceable outcomes, unit economics, technical maturity and partner requirements.
For a pilot or testbed, define the site, customer, use case, data, integration, acceptance, commercial follow-on and intellectual-property position. A free demonstration with no conversion route may not answer a growth question.
For cross-border research and development, identify the foreign collaborator, work split, background IP, project milestones and market potential. Coordinate formal agreements with appropriate legal advisers.
Compare pathway evidence
Create a two-column test. Launch evidence includes uncertain customer assumptions, early interviews, limited local data and a need for market discovery. Grow evidence includes validated demand, a clear offer, delivery resources and a defined scaling or technology milestone.
Score each item using source evidence and management judgment. Do not manufacture maturity to enter a preferred cohort. The wrong route can create commitments before the team knows what market problem it is solving.
If evidence is mixed, choose the smaller decision. A focused Launch sprint can prevent a costly Grow plan built on untested demand.
Assess GIA+ separately
The official GIA+ page supports eligible Singapore-based startups joining selected global cohorts and states enhanced support of up to 70% from 1 April 2026, subject to programme caps and qualifying cost items.
GIA+ is not a general reimbursement for any overseas accelerator. Confirm that the programme partner is curated, the company is onboarded through the required route and the costs match current terms.
Compare programme fees, in-market costs, internal time, travel and opportunity cost. Model the project without support before committing.
Build the evidence calendar
For Launch, schedule customer interviews, partner conversations, competitor checks, regulatory questions and a final market decision. For Grow, schedule pilot milestones, technical acceptance, partner performance, pipeline and scale economics.
Record evidence as fact, inference or unresolved question. A prospective partner’s enthusiasm is not a purchase order. A meeting count is not proof of demand.
Use weekly review to change hypotheses or stop activities that no longer serve the decision. Keep the strongest negative evidence because it can save later cost.
Decide what happens after the programme
Set proceed, revise and stop rules before travel or partner work begins. A proceed decision should identify budget, local ownership, partner terms, hiring, tax, licensing and next commercial milestones.
The Singapore trading-model guide addresses a different incentive and operating question. The foreign-company entry guide remains the market-entry cornerstone.
A Global Innovation Alliance Launch or Grow choice is sound when the company can state what it knows, what it needs to learn and which commitment follows the evidence. The network creates access; the company must still make a disciplined market decision.
## Apply a route decision at each market milestone
At the end of discovery, ask whether the company has evidence of a problem worth solving, an identifiable buyer and a practical way to test demand. If not, remain in validation rather than building a premature expansion budget.
At the end of the first pilot, assess repeatability: sales cycle, local adaptations, partner dependence, delivery cost, regulatory friction and the reason a second customer would buy. This is the point to consider whether a Grow-oriented programme or another support route matches the next stage.
Record a stop decision when evidence is weak. A market can be attractive in general while being wrong for the company’s current product, timing or resources. Keeping the rejected hypothesis and data prevents the next team from repeating the same unsupported assumptions.